1 / 8

Global Genitourinary Drugs Market Size 2011-2015:

echNavio's analysts forecast the Global Genitourinary Drugs market to grow at a CAGR of 3.05 percent over the period 2011-2015. One of the key factors contributing to this market growth is the entry of novel biological drugs. The Global Genitourinary Drugs market has also been witnessing a paradigm shift toward biological drugs. However, lack of adherence to medication could pose a challenge to the growth of this market. To Browse This Report: http://www.marketresearchreports.biz/analysis/147925 To Browse All Reports: http://www.marketresearchreports.biz/

mrrbiz
Download Presentation

Global Genitourinary Drugs Market Size 2011-2015:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Genitourinary Drugs Market 2011-2015 TechNavio's analysts forecast the Global Genitourinary Drugs market to grow at a CAGR of 3.05 percent over the period 2011-2015. To Browse This Report Click : http://www.marketresearchreports.biz/analysis/147925

  2. Description TechNavio'sanalysts forecast the Global Genitourinary Drugs market to grow at a CAGR of 3.05 percent over the period 2011-2015. One of the key factors contributing to this market growth is the entry of novel biological drugs. The Global Genitourinary Drugs market has also been witnessing a paradigm shift toward biological drugs. However, lack of adherence to medication could pose a challenge to the growth of this market. TechNavio's report, the Global Genitourinary Drugs Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Genitourinary Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.The key vendors dominating this space are Abbott Laboratories, AstellasPharma Inc., Bayer AG, Eli Lilly and Co., GlaxoSmithKline plc, Merck and Co. Inc., and Pfizer Inc.Other vendors mentioned in the report are Agile Therapeutics Inc., Allergan Inc., AntaresPharma Inc., BoehringerIngelheim GmbH, Dong-A Pharmaceutical Co. Ltd., Detrol LA, Ferring Holding S.A., Kissei Pharmaceutical Co. Ltd., Merck Serono S.A., Novartis International AG, Novo Nordisk A/S, Nymox Pharmaceutical Corp., PregLem S.A., RecordatiS.p.A., RottapharmS.p.A., Teva Pharmaceutical Industries Ltd., VIVUS Inc., Warner Chilcott plc, and Watson Pharmaceuticals Inc.

  3. Key questions answered in this report What will the market size be in 2015 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?

  4. Table of Content 1. Executive Summar 2. Introduction 3. Market Coverage Market Overview Key Products 4. Market Landscape 4.1 Global Genitourinary Drugs Market Market Size Market Forecast 4.2 Genitourinary Drugs Market in the US Market Size Market Forecast 4.3 Genitourinary Drugs Market in Japan

  5. Market Size Market Forecast 4.4 Key Market Segmentation Hormonal Contraception BPH Erectile Dysfunction Urinary Incontinence Infertility Infection 4.5 Five Forces Analysis 5. Geographical Segmentation 6. Key Leading Countries US Japan Germany

  6. 7. Vendor Landscape 8. Buying Criteria 9. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Key Vendor Analysis 14.1 Pfizer Inc. Business Overview SWOT Analysis 14.2 Bayer AG Business Overview SWOT Analysis 14.3 Eli Lilly and Co. Business Overview SWOT Analysis 14.4 Merck and Co. Inc. Business Overview SWOT Analysis 14.5 AstellasPharma Inc. Business Overview SWOT Analysis 14.6 GlaxoSmithKline plc Business Overview SWOT Analysis 14.7 Abbott Laboratories Business Overview SWOT Analysis

  7. 14.4 Merck and Co. Inc. Business Overview SWOT Analysis 14.5 AstellasPharma Inc. Business Overview SWOT Analysis 14.6 GlaxoSmithKline plc Business Overview SWOT Analysis 14.7 Abbott Laboratories Business Overview SWOT Analysis

  8. We are a one stop solution for all your research needs. Contact Information To Browse This Report: Click Below Link http://www.marketresearchreports.biz/analysis/147925 To Browse All Reports of this Publisher : Click Below Link http://www.marketresearchreports.biz/publisher/73 To Browse All Reports : Visit http://www.marketresearchreports.biz/

More Related